PolyPid to Deliver Poster Presentation at SAGES 2022

Presentation Evaluates Efficacy of D-PLEX 100 in Reducing Surgical Site Infection Rates in Elective Colorectal Surgery PETACH TIKVA, Israel , March 08, 2022 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD ) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical